...
首页> 外文期刊>BMC Neuroscience >Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response
【24h】

Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response

机译:婴幼儿神经元类固醇脂褐变的小鼠模型中的基因表达谱揭示了炎症反应的早期早期基因和介质的上调

获取原文
           

摘要

Background The infantile form of neuronal ceroid lipofuscinosis (also known as infantile Batten disease) is caused by hereditary deficiency of a lysosomal enzyme, palmitoyl-protein thioesterase-1 (PPT1), and is characterized by severe cortical degeneration with blindness and cognitive and motor dysfunction. The PPT1-deficient knockout mouse recapitulates the key features of the disorder, including seizures and death by 7–9 months of age. In the current study, we compared gene expression profiles of whole brain from PPT1 knockout and normal mice at 3, 5 and 8 months of age to identify temporal changes in molecular pathways implicated in disease pathogenesis. Results A total of 267 genes were significantly (approximately 2-fold) up- or downregulated over the course of the disease. Immediate early genes (Arc, Cyr61, c-fos, jun-b, btg2, NR4A1) were among the first genes upregulated during the presymptomatic period whereas immune response genes dominated at later time points. Chemokine ligands and protease inhibitors were among the most transcriptionally responsive genes. Neuronal survival factors (IGF-1 and CNTF) and a negative regulator of neuronal apoptosis (DAP kinase-1) were upregulated late in the course of the disease. Few genes were downregulated; these included the α2 subunit of the GABA-A receptor, a component of cortical and hippocampal neurons, and Hes5, a transcription factor important in neuronal differentiation. Conclusion A molecular description of gene expression changes occurring in the brain throughout the course of neuronal ceroid lipofuscinosis suggests distinct phases of disease progression, provides clues to potential markers of disease activity, and points to new targets for therapy.
机译:背景技术神经元类脂褐质病的婴儿型(也称为婴儿巴顿病)是由溶酶体酶,棕榈酰蛋白硫酯酶-1(PPT1)的遗传缺陷引起的,其特征是严重的皮质变性伴失明以及认知和运动功能障碍。缺乏PPT1的基因敲除小鼠概括了该疾病的主要特征,包括7-9个月大时的癫痫发作和死亡。在当前的研究中,我们比较了PPT1基因敲除小鼠和正常小鼠在3、5和8个月大时全脑的基因表达谱,以确定与疾病发病机制有关的分子途径的暂时变化。结果在整个疾病过程中,共有267个基因显着(约2倍)上调或下调。立即早期基因(Arc,Cyr61,c-fos,jun-b,btg2,NR4A1)是在症状前期上调的首批基因,而免疫反应基因则在随后的时间点占主导地位。趋化因子配体和蛋白酶抑制剂是转录响应最强的基因之一。神经元生存因子(IGF-1和CNTF)和神经元凋亡的负调节剂(DAP激酶-1)在疾病晚期被上调。很少有基因被下调;其中包括GABA-A受体的α2亚基(皮层和海马神经元的组成部分)和Hes5(对神经元分化很重要的转录因子)。结论整个神经元类脂褐藻病病程中大脑中发生的基因表达变化的分子描述提示疾病进展的不同阶段,为疾病活动的潜在标志物提供了线索,并指出了新的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号